R&D/Clinical Trials

Latest News

Viking Therapeutics Reveals Positive Results from Oral Obesity Drug
Viking Therapeutics Reveals Positive Results from Oral Obesity Drug

March 26th 2024

Reportedly, the oral weight loss pill VK2735 showed promising signs of effectiveness and a tolerable safety profile.

TNO Launches Peregrion, Aiming to Increase Market Presence of Accelerated Biomedical Mass Spectrometry Technology
TNO Launches Peregrion, Aiming to Increase Market Presence of Accelerated Biomedical Mass Spectrometry Technology

March 26th 2024

Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer
Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer

March 22nd 2024

Joel Latham, President and CEO of Incannex Healthcare Inc
Navigating the CBD Research Landscape: Unveiling Best Practices in the Post-MMCREA Era

March 14th 2024

Lexicon Aims to Resubmit New Drug Application for Type 1 Diabetes Treatment Sotagliflozin to the FDA Later This Year
Lexicon Aims to Resubmit New Drug Application for Type 1 Diabetes Treatment Sotagliflozin to the FDA Later This Year

March 14th 2024

Video Interviews
Podcasts

More News